Abstract
According to “Russian Pharma Sector Analysis”, the Russian
pharmaceutical market grew at a slow pace in 2007 but it still is attractive
as compared to previous years that recorded no-so-impressive performance due
to the state segment. In the Russian pharma market, both the retail segment
and parapharmaceutical market registered double-digit growth in sales value,
with parapharmaceutical recording the highest growth rate and retail segment
contributing the maximum share in sales value terms.
This research report provides an extensive research and objective analysis on
the growing demand of pharmaceuticals in Russia and presents a clear picture
of the country' s healthcare and pharmaceutical market. It covers Russian
demographics, structure of healthcare sector, size and growth of
pharmaceutical market, leading drugs, segment-wise break up, and information
on major therapy areas to give strategic insight into the market. This report
briefly discusses the major players operating in each segment of the market.
The share of imported and domestic drugs, RX and OTC drugs, and sales
structure by ATC group has also been analyzed in context of the Russian
pharmaceutical market.
Key Research Findings
- The Russian pharmaceutical market grew 16% in 2007 as compared to 2006.
- State segment grew at a slower rate while the parapharmaceutical and
commercial segments recorded impressive growth rates in 2007.
- In 2007, new drugs segment increased at fast pace as more than 230 new
drug trade names appeared in the Russian pharmaceutical market.
- In 2007, Sanofi-Aventis was the leader of the retail sales among the drug
manufacturers in commercial drug market segment.
- The consumption value provided by the State Reimbursement Program (DLO)
decreased in 2007 due to diminishing requirement.
- The Russian pharmaceutical market is forecasted to grow at a CAGR of
14.36% by 2012.
Key Issues Analyzed in the Report
- Where does the Russian pharmaceutical market stand in comparison to other
key global markets?
- What is the market size of various segments in the Russian pharmaceutical
industry?
- What is the proportion of domestic and imported drugs in each segment?
- What are the opportunities that will emerge in future for the market?
- Who are the major players in the Russian pharmaceutical market?
Research Methodology Used in the Report
Information Sources
The information in this report has been taken from various credible sources
like books, newspapers, trade journals, white papers, industry portals,
government agencies, trade associations, monitoring industry news and
developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods used in this report include ratio analysis, historical
trend analysis, linear regression analysis using software tools, judgmental
forecasting, and cause and effect analysis.
For the purpose of this report, the Russian pharmaceutical market has been considered to consist of the following segments:
- Commercial drugs market;
- State segment (DLO programme and Hospital Segment)
- Parapharmaceutical segment (Food Supplements and Cosmetics)
| 
View Cart
